Risk of thromboembolic phenomena in patients with inflammatory bowel disease

被引:7
|
作者
Suarez Ferrer, Cristina [1 ]
Vera Mendoza, Maria Isabel [1 ]
Amo San Roman, Leticia [1 ]
Gonzalez Lama, Yago [1 ]
Calvo Moya, Marta [1 ]
Garcia Casas, Mercedes [1 ]
Abreu Garcia, Luis [1 ]
机构
[1] Hosp Univ Puerta de Hierro, Serv Gastroenterol & Hepatol, Madrid, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2012年 / 35卷 / 09期
关键词
Thromboembolic phenomena; Inflammatory bowel disease; Risk of thrombosis; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM;
D O I
10.1016/j.gastrohep.2012.07.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Inflammatory bowel disease (IBD) is an independent risk factor for thromboembolic phenomena (TEP). We evaluated the prevalence and the possible risk factors associated with developing TEP in patients with IBD in our center. Material and methods: Data were retrospectively collected from January 1995 to December 2011 from 23 patients. A total of 61% were diagnosed with Crohn's disease (CD) and 39% with ulcerative colitis (UC) according to routine criteria. Results: When the Montreal classification was used, 58% of the patients with CD had an inflammatory pattern (B1), 25% a stenosing pattern (B2) and 17% a fistulizing pattern (B3). Half the patients had ileocolic involvement (L3), one-third had colonic involvement (L2) and the remainder had Heal involvement (L1). Among patients with UC according to the Montreal classification, 78% had extensive colitis (E3), 11% had left colonic involvement (E2) and 11% had proctocolitis (El). During the event, almost half the patients with UC had severe inflammatory activity (S3; 44%), 33% had mild-moderate activity (51: 22%, S2: 11%) and only 22% were in remission (SO). Overall, at the time of the TEP, 48% of the patients had mild-moderate activity and 22% had severe activity. Likewise, 44% were hospitalized at the time of the event. In UC, an increase in the prevalence of TEP was found in admitted patients (66%). None of the patients had a family history of TER two patients (9%) had associated thrombophilia and 26% were active smokers. There were no TEP during pregnancy. Only one patient was taking contraceptive pills when the event occurred. The most frequent forms of TEP were deep vein thrombosis of the legs (55%) followed by pulmonary thromboembolism (25%). Conclusions: TEP are relatively frequent in patients with IBD, with a strong impact on morbidity and mortality. In our series, risk factors for these events were more extensive involvement (any of the groups) and severe inflammatory activity. No significant association between classical risk factors such as the use of contraceptives, pregnancy, coagulation disorders or smoking and the risk of TEP were found. (C) 2012 Elsevier Espana, S.L. and AEEH y AEG. All rights reserved.
引用
收藏
页码:634 / 639
页数:6
相关论文
共 50 条
  • [1] Thromboembolic phenomena in inflammatory bowel disease and risk with JAK inhibitor treatments
    Garcia, Jose Luis Rueda
    Benitez, Jose Manuel
    Rey, Iria Baston
    Sard, Margalida Calafat
    Ferrer, Cristina Suarez
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2025, 48 (01):
  • [2] INFLAMMATORY BOWEL DISEASE AND THE RISK OF THROMBOEMBOLIC DISEASE
    Kumar, A.
    Disney, B. R.
    Wood, L.
    Slater, J.
    de Silva, S.
    GUT, 2015, 64 : A84 - A85
  • [3] THROMBOEMBOLIC RISK IN INFLAMMATORY BOWEL-DISEASE
    HUPPE, D
    KAMP, U
    KRIEG, M
    STRAUB, H
    KUNTZ, HD
    MAY, B
    MEDIZINISCHE KLINIK, 1988, 83 (18) : 577 - 584
  • [4] Thromboembolic Events in Patients with Inflammatory Bowel Disease
    Algahtani, Farjah H.
    Farag, Youssef M. K.
    Aljebreen, Abdulrahman M.
    Alazzam, Nahla A.
    Aleem, Aamer S.
    Jabri, Fouad F.
    Rajab, Mohammad H.
    Shoukri, Mohamed M.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2016, 22 (06): : 423 - 427
  • [5] Thromboembolic Management in Patients With Inflammatory Bowel Disease
    Savoie, Blake D.
    Hamer, Diana
    Chapman, Casey
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1384 - S1385
  • [6] Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
    Setyawan, Juliana
    Mu, Fan
    Zichlin, Miriam L.
    Billmyer, Emma
    Downes, Nathaniel
    Yang, Hongbo
    Azimi, Nassir
    Strand, Vibeke
    Yarur, Andres
    ADVANCES IN THERAPY, 2022, 39 (01) : 738 - 753
  • [7] Risk of Thromboembolic Events and Associated Healthcare Costs in Patients with Inflammatory Bowel Disease
    Juliana Setyawan
    Fan Mu
    Miriam L. Zichlin
    Emma Billmyer
    Nathaniel Downes
    Hongbo Yang
    Nassir Azimi
    Vibeke Strand
    Andres Yarur
    Advances in Therapy, 2022, 39 : 738 - 753
  • [8] Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease
    Alfred D. Nelson
    Daniela Fluxá
    Freddy Caldera
    Francis A. Farraye
    Jana G. Hashash
    Paul T. Kröner
    Digestive Diseases and Sciences, 2023, 68 : 2597 - 2603
  • [9] Thromboembolic Events in Hospitalized Patients with Inflammatory Bowel Disease
    Nelson, Alfred D.
    Fluxa, Daniela
    Caldera, Freddy
    Farraye, Francis A.
    Hashash, Jana G.
    Kroner, Paul T.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2597 - 2603
  • [10] Thromboembolic Disease in Inflammatory Bowel Disease
    Irving, Peter
    Rampton, David
    PRACTICAL GASTROENTEROLOGY, 2007, 31 (07) : 26 - 36